Company · CIK 1343009
CNBX Pharmaceuticals Inc.
| CIK | 1343009 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | MD |
| Listed | CNBX (OTC) |
| First annual or quarterly report | 2009-01-13 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-262856 | 2022-02-18 | 2022-12-27 | 2 | |
| 333-255948 | 2021-05-10 | 2021-05-17 | 2 | |
| 333-252454 | 2021-01-27 | 2021-03-11 | 3 | |
| 333-216845 | 2017-03-21 | 2018-09-26 | 4 | |
| 333-192759 | 2013-12-11 | 2014-02-20 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-12-27 | RWWithdrawn | 333-262856 | 0001683168-22-008633 |
| 2022-02-18 | S-1Registration filed | 333-262856 | 0001683168-22-001154 |
| 2021-05-17 | EFFECTDeclared effective | 333-255948 | 9999999995-21-001982 |
| 2021-05-10 | S-1Registration filed | 333-255948 | 0001683168-21-001843 |
| 2021-03-11 | EFFECTDeclared effective | 333-252454 | 9999999995-21-000904 |
| 2021-02-23 | S-1/AAmendment | 333-252454 | 0001683168-21-000676 |
| 2021-01-27 | S-1Registration filed | 333-252454 | 0001683168-21-000268 |
| 2018-09-26 | 424B5Shelf takedown | 333-216845 | 0001683168-18-002842 |
| 2017-05-10 | 424B5Shelf takedown | 333-216845 | 0001683168-17-001143 |
| 2017-04-21 | EFFECTDeclared effective | 333-216845 | 9999999995-17-000899 |
| 2017-03-21 | S-3Shelf registered | 333-216845 | 0001683168-17-000616 |
| 2014-02-20 | EFFECTDeclared effective | 333-192759 | 9999999995-14-000494 |
| 2014-02-11 | S-1/AAmendment | 333-192759 | 0001303681-14-000017 |
| 2014-01-31 | S-1/AAmendment | 333-192759 | 0001303681-14-000012 |
| 2014-01-24 | S-1/AAmendment | 333-192759 | 0001303681-14-000008 |
| 2013-12-11 | S-1Registration filed | 333-192759 | 0001303681-13-000117 |